Efficacy and Safety Comparison of Sitagliptin and Glimepiride in Elderly Japanese Patients With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms START-J
- Sponsors Banyu; Merck Sharp & Dohme
- 10 Jun 2017 Biomarkers information updated
- 14 Jun 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan. (UMIN000004721)
- 25 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan (UMIN000004047).